Though patients with type 2 diabetes or chronic kidney disease (CKD) face a greater risk of heart failure (HF) following acute myocardial infarction (AMI), patients without those comorbidities also ...
As a class, sodium–glucose transporter 2 inhibitors are novel drugs initially developed for glycemic control in patients with type 2 diabetes. [Cowie MR, et al. Nat Rev Cardiol. 2020;1a] Their primary ...
The double-blind EMPEROR-Reduced trial enrolled 3730 adults with HFrEF, with and without diabetes. Boehringer Ingelheim and Lilly announced positive topline results from a phase 3 trial evaluating the ...
The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two ...
Dear Dr. Roach: I am a 64-year-old male, and my A1C level has been averaging around 7.4% for a number of years. I was diagnosed diabetic at age 54. My doctor has been trying several combinations of ...
DEAR DR. ROACH: I am a 64-year-old male, and my A1C level has been averaging around 7.4% for a number of years. I was diagnosed diabetic at age 54. My doctor has been trying several combinations of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback